Search results
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 19 hours agoA spokesman for Moderna said they hoped the jab would be available for the 2025 or 2026 flu season....
Harlingen receives updated COVID-19 boosters, to begin administrating Friday
KRGV Rio Grande Valley· 6 days agoThe booster shot will be available at a clinic from 1 p.m. to 7 p.m. at the Harlingen Health...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 21 hours agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 23 hours agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 1 day agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 4 days agoThe information in this article is current as of the date...
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 5 days agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 6 days agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 5 days agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days ago"Recall that consumer hesitancy regarding Covid boosters has been driven in part by fears about...